UK-based software, MEMORI, earns distinction as the nation's first certified software-as-a-medical device, offering real-time infection prediction capabilities.
Sanome's MEMORI, an AI-enabled warning system, is making significant strides in supporting the UK's National Health Service (NHS) in its 10-Year Plan. This innovative technology is designed to predict and prevent healthcare-associated infections (HAIs) up to 72 hours earlier than traditional methods, contributing to the NHS's objectives of prevention, early intervention, reducing complications, and lowering costs [1].
MEMORI, the first UK-developed AI medical device with Class IIb CE certification and MHRA approval, demonstrates its safety and effectiveness for clinical use. By integrating MEMORI into NHS workflows, the system aligns with the NHS 10-Year Plan’s ambition to improve patient safety and system efficiency through technology-driven preventive care [1][3].
The system analyses live patient data, including vitals, and clinical notes from the electronic patient record (EPR), delivering explainable alerts directly into a clinician's workflow [2]. This early detection can help the NHS reduce the approximately £2.7 billion cost and 7 million hospital bed days attributed to HAIs annually [1].
Benedikt von Thüngen, Sanome Founder and CEO, expressed pride in supporting a UK-grown solution that combines world-class science with a deep understanding of frontline healthcare. Von Thüngen emphasised that MEMORI was created to prevent others from experiencing what he did, when his father died in hospital due to missed early warning signs [4].
Lord James Bethell, a new strategic advisor for Sanome, stated that MEMORI is a transformative tool that allows clinicians to act sooner with more targeted interventions, saving lives and reducing the pressures on the healthcare system [5]. The MHRA is also leading the safe use of AI in healthcare as the first country in a new global network [6].
Sanome is actively working towards FDA approval and is collaborating with NHS Trusts and technology providers on various data-sharing initiatives. The company is expected to announce additional partnerships and validation results in the UK, Europe, and US later this year [7]. The support of Sanome's expert advisory board, who have firsthand experience of what it takes to achieve radical change in healthcare, further reinforces Sanome's role in shaping the future of healthcare [2].
In conclusion, MEMORI's AI-driven early infection prediction directly supports the NHS's 10-Year Plan by: - Detecting infections up to 72 hours earlier for timely clinical response - Reducing healthcare costs and complications from HAIs - Increasing hospital bed capacity by preventing infection spread - Enabling prevention and early intervention to improve patient outcomes
MEMORI acts as a critical technological tool aiding the NHS's long-term strategy to improve healthcare quality and sustainability [1].
[1] Sanome Press Release, 2021 [2] Sanome Website, 2021 [3] NHS 10-Year Plan, 2019 [4] BBC News, 2021 [5] Sanome Press Release, 2021 [6] MHRA Website, 2021 [7] Sanome Website, 2021
Read also:
- Psychology Major Shining Spot: Adriana Milko, graduating '24, showcasing her academic journey
- International translation service overview: Explore various global translation providers for seamless language conversion across the globe.
- Bolstering Indigenous Communities' Human Rights and Health in Chiapas: The Role of ACAS, A.C.
- School Emotional Awareness: Strategies to Empower Child's Success
